UnknownNot Applicable

Blue Laser Imaging (BLI) for Detection of Secondary Head and Neck Cancer

Germany140 participantsStarted 2020-09-22

Plain-language summary

This study wants to focus on Carcinoma detection rates with blue laser imaging (BLI) for participants with head-neck cancer who need a percutaneous endoscopic gastrostomy (PEG). BLI is a new imaging technique that can easily be used within a standard gastroscopy.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All participants with the need of PEG due to head neck cancers or esophageal carcinoma Exclusion Criteria: * Minors, pregnant women, contraindication for endoscopy, contraindications for establishment of a PEG

What they're measuring

Detection rate of a second cancer or precancerous lesions

Timeframe: The time frame is during the PEG insertion (approximately 15min)

Trial details

NCT IDNCT04566367

SponsorGeorg Dultz

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-02-02

View on ClinicalTrials.gov More Head Neck Cancer trials